Japan is about to undergo a major shift in its cannabis policy. Starting December 12th, the country will criminalize personal use of cannabis while simultaneously legalizing medical products derived from the plant. This move, confirmed by Japan’s health ministry, aims to regulate cannabis use and expand access to cannabis-derived medicines for patients.
For decades, Japan has prohibited the possession and cultivation of marijuana, but it has never penalized its use. This loophole was meant to protect hemp farmers who might absorb trace amounts of cannabis compounds while cultivating hemp for industrial purposes. However, growing concerns about drug abuse, particularly among young people, have prompted the government to change its stance. The new law will make using cannabis illegal, with offenders facing up to seven years in prison. Authorities hope this strict approach will deter drug misuse. This shift marks a departure from Japan’s traditionally zero-tolerance drug policy, extending control to even personal use.
On the other hand, Japan is opening the door to medical marijuana products. The revised laws will allow for the prescription and use of cannabis-derived medicines, a major victory for patients who have been advocating for wider access to these treatments. While cannabis-based drugs have been limited to clinical trials in Japan, this new legal framework will allow for their use in medical care. Patient groups have been particularly vocal in pushing for cannabidiol (CBD) medicines, which are already approved in many countries, including Europe and the United States. These drugs are used to treat conditions like severe epilepsy. This legal change brings hope to patients who have struggled to find effective treatments under Japan’s previously restrictive drug policies.
